Many people throughout the UK are experiencing a puzzling and severe skin disorder that has confounded medical professionals. Sufferers experience their skin badly inflamed, cracked and flaking, frequently across their whole body, yet many doctors struggle to diagnose or treat the condition. The condition, referred to as topical steroid withdrawal (TSW) or red skin syndrome, has sparked unprecedented interest on online platforms, with footage showing patients’ experiences receiving more than a billion views on TikTok alone. Although it affects a increasing number of people, TSW remains so poorly understood that some doctors and dermatologists doubt whether it exists at all. Now, for the first time, researchers across the UK are launching a major study to determine what is causing these unexplainable symptoms and reasons why some people develop the condition whereas others do not.
The Unexplained Condition Spreading Across the UK
Bethany Gamble’s story exemplifies the devastating impact of topical steroid withdrawal on those affected. The 21-year-old from Birmingham had controlled her eczema successfully with steroid creams since childhood, but at eighteen, her condition worsened considerably. Her skin became severely inflamed and reddened, breaking and leaking whilst the itching became what she characterises as “bone deep”. Within two years, the pain had become so acute that she was confined to her bed, needing constant care from her mother. Most concerning, Bethany experienced repeated dismissal by healthcare providers who attributed her symptoms to standard eczema and kept prescribing the very treatments she believed were causing her suffering.
The medical establishment is split on how to address TSW, with deep divisions about its basic nature. Some experts consider it a severe allergic response to the steroid-based creams that serve as the primary treatment for eczema across the NHS. Others argue it amounts to a severe flare-up of pre-existing skin conditions rather than a separate syndrome, whilst a small number remain unconvinced of its existence altogether. This professional uncertainty has placed patients like Bethany caught in a state of diagnostic limbo, struggling to access appropriate treatment. The absence of agreement has encouraged Professor Sara Brown at the University of Edinburgh to establish the first major UK research project examining TSW, funded by the National Eczema Society.
- Symptoms involve significant swelling, skin fissuring and intense itching throughout the body
- Patients report “elephant skin” thickening and extreme shedding of keratinised cells
- Healthcare practitioners frequently overlook TSW as standard eczema or decline to recognise it
- The condition may prove so incapacitating that sufferers find themselves unable to perform daily activities
Living with Steroid Topical Withdrawal
From Manageable Eczema to Debilitating Symptoms
For numerous patients, topical steroid withdrawal constitutes a severe decline from a previously stable skin condition. What begins as intermittent itching in areas of skin fold can rapidly escalate into a widespread inflammatory reaction that renders patients incapable of functioning. The transition often occurs suddenly, without warning, converting a controllable long-term condition into an severe medical emergency. Patients report their skin becoming intensely hot, inflamed and red, with significant cracking and weeping that demands constant attention. The physical toll is worsened by exhaustion, as the relentless itching disrupts sleep and healing, establishing a destructive cycle of deterioration.
The speed at which TSW progresses takes many sufferers off guard. Those who have lived with eczema for years, sometimes decades, are unprepared for the magnitude of symptoms that appear when their condition rapidly deteriorates. Simple daily activities become overwhelming difficulties: showering becomes excruciating, dressing requires assistance, and preserving hygiene demands considerable exertion. Some patients describe feeling as though their skin is being ravaged from within, with inflammation moving through their body in patterns that bear little resemblance to their previous eczema flare-ups. This marked shift often drives sufferers to seek urgent medical help, only to meet with doubt from healthcare professionals.
The Battle for Recognition
Perhaps the most distressing aspect of topical steroid withdrawal is the medical gaslighting that frequently accompanies it. Patients experiencing serious, unexplained health issues are consistently informed they merely suffer from eczema flaring up, despite their assertion that this is essentially distinct from anything they’ve experienced before. Doctors often respond by prescribing stronger steroids or increased doses, potentially worsening the very condition patients suspect the topical treatments triggered. This cycle of dismissal leaves sufferers experiencing abandonment by the medical establishment, forced to navigate their illness alone whilst being informed that their personal experience lacks validity. Many patients report feeling gaslit repeatedly, their worries disregarded as emotional or psychological in nature rather than actual physical health issues.
The absence of medical consensus has created a dangerous gap between what patients report and clinical acknowledgement. Without established diagnostic standards or established treatment protocols, GPs and dermatologists struggle to identify TSW or offer appropriate support. Some practitioners remain entirely unconvinced the condition exists, treating all severe presentations as typical eczema or other known dermatological conditions. This professional uncertainty results in delayed diagnosis, unsuitable therapies and significant emotional suffering for patients already suffering physically. The increased prominence of TSW on social media has highlighted this diagnostic void, encouraging investigation to examine the experiences reported by vast numbers of individuals, even as the medical establishment remains divided on how to respond.
- Symptoms can emerge suddenly in individuals with formerly controlled eczema managed by topical steroids
- Patients often face scepticism from healthcare professionals who attribute deterioration to standard eczema flares
- Healthcare providers continue to disagree on whether TSW is a genuine condition or acute eczema flare-up
- Lack of established diagnostic standards means numerous patients find it difficult to obtain appropriate treatment and assistance
- Social media has magnified voices of patients, with TSW hashtags reaching over a billion views globally
Racial Disparities in Diagnostic and Treatment Pathways
The diagnostic difficulties surrounding topical steroid withdrawal become more acute amongst individuals with darker skin, where symptoms can be significantly harder to identify visually. Erythema and inflammatory responses, the defining features of TSW in those with lighter complexions, present distinctly across different ethnic groups, yet many diagnostic frameworks remain based around how the condition appears in white patients. This disparity means that individuals from Black, Asian and minority ethnic backgrounds experiencing TSW often face substantially longer periods in identification and acceptance. Healthcare professionals trained chiefly via manifestations in lighter-skinned individuals may fail to recognise the typical indicators, leading to continued misidentification and unsuitable therapeutic suggestions that can intensify distress.
Research into TSW has historically overlooked the lived experiences with darker complexions, sustaining a pattern where their symptoms remain insufficiently documented and inadequately researched. The social media conversations dominating TSW discussions have been predominantly influenced by voices with lighter skin, risking distortion of medical understanding and public awareness. As Professor Sara Brown’s groundbreaking UK study advances, guaranteeing inclusive participation amongst research participants will be essential to creating genuinely comprehensive diagnostic frameworks and therapeutic strategies. Without deliberate efforts to prioritise the perspectives of all ethnic groups, treatment inequalities in TSW identification and care risk widening further, abandoning at-risk communities without sufficient assistance or solutions.
| Skin Tone | TSW Appearance |
|---|---|
| Light/Fair | Bright red inflammation, visible flushing and erythema across affected areas |
| Medium/Olive | Darker red or brownish discolouration with less pronounced visible redness |
| Dark/Deep | Purple-toned or ashen discolouration, with inflammation appearing as hyperpigmentation or hypopigmentation |
| Very Dark | Subtle changes in skin texture and tone, with inflammation manifesting as dark patches or loss of pigmentation |
Research and Treatment Options Emerging
First Major UK Investigation Currently Happening
Professor Sara Brown’s pioneering research at the University of Edinburgh marks a turning point for TSW sufferers seeking validation and understanding. With backing from the National Eczema Society, the study has brought together hundreds of participants throughout the United Kingdom to investigate the physiological processes underlying topical steroid withdrawal. By assessing symptoms, saliva samples and skin biopsies, researchers hope to identify why particular individuals exhibit TSW whilst others on identical steroid regimens do not. This detailed analysis marks a notable change from dismissal to thorough inquiry.
The investigative group partnering with Dr Alice Burleigh from patients’ support organisation Scratch That, brings both clinical expertise and lived experience to the investigation. Their joint methodology recognises that patients hold essential understanding into their health situations. Professor Brown has identified patterns in TSW that cannot be explained by conventional eczema understanding, including marked “elephant skin” thickening, severe shedding and clearly defined zones of inflammation. The study’s findings could significantly transform how doctors handle diagnosis and care of this serious condition.
Treatment Options and Their Limitations
Currently, treatment options for TSW are quite limited and commonly disappointing. Many medical practitioners persist in prescribing topical steroids despite evidence suggesting they may exacerbate symptoms in vulnerable patients. Some patients describe short-term improvement from emollients, antihistamines and oral medications, though results vary widely. Dermatologists are split on most effective management plans, with some recommending full steroid withdrawal whilst others suggest slow reduction. This absence of agreement leaves patients navigating their care journeys mostly in isolation, drawing substantially on peer support networks and digital communities for advice.
Psychological assistance with specialist dermatological care offer potential benefits, yet access is inconsistent across the NHS. Some patients have explored alternative approaches including dietary modifications, managing environmental factors and holistic therapies, though scientific evidence validating such approaches remains sparse. The absence of established clinical protocols means treatment decisions often depend on individual dermatologist experience and patient preference rather than research-informed standards. Until robust research yields conclusive findings, TSW sufferers frequently describe feeling abandoned by conventional medicine.
- Emollient creams and hydrating products to support the skin’s protective barrier and decrease water loss
- Antihistamine medications to manage itching and associated sleep disturbance during flare-ups
- Systemic corticosteroids or immune-suppressing agents for serious presentations with specialist oversight
- Psychological counselling to address emotional distress and worry related to prolonged skin suffering
Expressions of Hope and Commitment
Despite the lack of clarity regarding TSW and the frequently dismissive attitudes from medical practitioners, patients are finding strength in shared community and collective experience. Online support networks have proven vital for those struggling with the disorder, offering validation and practical advice when traditional medicine has failed them. Many sufferers describe the point at which they found the TSW hashtag as transformative—finally finding others with the same symptoms and realising they were not alone in their experience. This collective voice has been powerful enough to trigger the initial serious research initiatives, showing that patient advocacy can advance medical understanding even when institutional structures remain sceptical.
Bethany Gamble and those facing comparable challenges are resolved to draw attention and push for appropriate acknowledgement of TSW within the healthcare sector. Their openness in recount personal stories of their struggles on online platforms has made discussions more commonplace around a disorder that numerous physicians still are unwilling to accept. These people are not sitting idly for solutions; they are taking part in scientific investigations, documenting their symptoms thoroughly, and insisting that their testimonies be treated with respect. Their fortitude in the confronting persistent distress and dismissive healthcare practices provides encouragement that answers may finally be within attainment, and that future patients will obtain the acknowledgement and treatment they urgently require.
- Community-driven research projects are filling gaps left by traditional medical institutions and advancing knowledge of TSW
- Digital support networks offer psychological assistance, practical coping strategies, and mutual recognition for isolated sufferers worldwide
- Advocacy efforts are gradually shifting medical perception, prompting dermatologists to examine rather than dismiss patient concerns
